Dementia and Geriatric Cognitive Disorders
Original Research Article
Neuropsychiatric Symptoms in Amnestic and Nonamnestic Mild Cognitive ImpairmentRozzini L.a, b · Vicini Chilovi B.a, b · Conti M.a · Delrio I.a · Borroni B.a · Trabucchi M.b · Padovani A.aaNeurological Clinic, University of Brescia, and bGeriatric Research Group, Brescia, Italy
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Accepted: May 09, 2007
Published online: November 19, 2007
Issue release date: December 2007
Number of Print Pages: 5
Number of Figures: 0
Number of Tables: 2
ISSN: 1420-8008 (Print)
eISSN: 1421-9824 (Online)
For additional information: https://www.karger.com/DEM
Abstract
Background: The information regarding neuropsychiatric symptoms in the subtypes of mild cognitive impairment (MCI) is inadequate. Objective: To describe the behavioral neuropsychiatric symptoms of MCI in two subgroups of MCI patients with different neuropsychological characteristics. Methods: MCI patients are classified as amnestic (aMCI) if they have a prominent memory impairment, either alone or with other cognitive impairments (multiple domains with amnesia), or nonamnestic (naMCI) if a single nonmemory domain is impaired alone or in combination with other nonmemory deficits (multiple domains without amnesia). The Neuropsychiatric Inventory (NPI) was administrated to detect behavioral and psychological disturbances observed by the caregiver. Results: 120 subjects were analyzed: 94 were classified as aMCI and 26 as naMCI. Subjects with aMCI were more compromised than those with naMCI on global cognitive functions. About 85% of MCI patients had some neuropsychiatric symptoms evaluated with the NPI and the most prevalent symptom was depression, followed by anxiety. A significantly higher prevalence of hallucinations and sleep disorders has been observed in the naMCI group in comparison with the aMCI group. Conclusion: Neuropsychiatric symptoms occur in the majority of persons with MCI and may be the earliest manifestation of different diseases, each one associated with different clinical profiles at the stage of MCI.
© 2007 S. Karger AG, Basel
Related Articles:
References
- Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303–308.
- Fischer P, Jungwirth S, Zehetmayer S, Weissgram S, Hoenigschnabl S, Gelpi E, Krampla W, Tragl KH: Conversion of subtypes of mild cognitive impairment to Alzheimer dementia. Neurology 2007;68:288–291.
- Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Bäckman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC: Mild cognitive impairment – Beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004;256:240–246.
- Artero S, Petersen R, Touchon J, Ritchie K: Revised criteria for mild cognitive impairment: validation within a longitudinal population study. Dement Geriatr Cogn Disord 2006;22:465–470.
- Frisoni GB, Rozzini L, Gozzetti A, Binetti G, Zanetti O, Bianchetti A, Trabucchi M, Cummings JL: Behavioral syndromes in Alzheimer’s disease: description and correlates. Dement Geriatr Cogn Disord 1999;10:130–138.
- Mega MS, Cummings JL, Fiorello T, Gornbein J: The spectrum of behavioral changes in Alzheimer’s disease. Neurology 1996;46:130–135.
- Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S: Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA 2002;288:1475–1483.
- Feldman H, Scheltens P, Scarpini E, Hermann N, Mesenbrink P, Mancione L, Tekin S, Lane R, Ferris S: Behavioral symptoms in mild cognitive impairment. Neurology 2004;62:1199–1201.
- Barnes DE, Alexopoulos GS, Lopez OL, Williamson JD, Yaffe K: Depressive symptoms, vascular disease, and mild cognitive impairment. Findings from the Cardiovascular Health Study. Arch Gen Psychiatry 2006;63:273–280.
- Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL: A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566–572.
- Folstein MF, Folstein SE, McHugh PR: ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.
- Fioravanti M, Nacca D, Buckley AE, Ferrario E, Varetto O, Mogni P, Fabris F: The Italian version of the Alzheimer’s Disease Assessment Scale (ADAS): psychometric and normative characteristics from a normal aged population. Arch Gerontol Geriatr 1994;19:21–30.
- Lawton MP, Brody EM: Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179–186.
- Katz S, Downs TD, Cash HR, Grotz RC: Progress in development of the index of ADL. Gerontologist 1970;10:20–30.
-
Sheikh JI, Yesavage JA: Geriatric Depression Scale (GDS): recent evidence and development of a shorter version; in Brink TL (ed): Clinical Gerontology: A Guide to Assessment and Intervention. New York, The Haworth Press, 1986, pp 165–173.
- Hamilton M: Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278–293.
- Cummings JL, Mega M, Gray K Rosenberg-Thompson S, Carusi DA, Gornbein J: The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308–2314.
-
Rey A: L’examen clinique en psychologie. Paris, Press Universaire de France, 1964.
-
Novelli G, Papagno C, Capitani E, Laiacona M, Cappa SF, Vallar G: Tre tests clinici di ricerca e produzione lessicale. Taratura su soggetti normali. Arch Psicol Neurol Psichiatr 1986;4:477–506.
- Bingham WC, Burke HR, Murray S: Raven’s Progressive Matrices: construct validity. J Psychol 1966;62:205–209.
-
Reitan RM: Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 1958;8:271–276.
External Resources
-
Osterrieth PA: Le test de copie d’une figure complexe: contribution à l’étude de la perception et la mémoire. Arch Psychol 1944;30:286–356.
-
Benton AL, Hamsher K: Multilingua Aphasia Examination. Iowa City, AJA Associates, 1983.
-
Fahn S, Elton RL: Members of the UPDRS development committee: unified Parkinson’s disease rating scale; in Fahn S, Marsden CD, Calne DB, Goldstein M (eds): Recent Developments in Parkinson’s Disease. Florham Park, MacMillan Healthcare Information, 1987, pp 153–304.
-
Statistical Package for the Social Sciences for Windows, Release 11.5.1 (Italian Version). Chicago, SPSS Inc, 2002.
- McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group. Neurology 1984;34:939–944.
- McKeith IG, Dickson DW, Lowe J, Emre M, O’Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M; Consortium on DLB: Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005;65:1863–1872.
- McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ; Work Group on Frontotemporal Dementia and Pick’s Disease: Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick’s Disease. Arch Neurol 2001;58:1803–1809.
-
World Health Organization: The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. Geneva, World Health Organization, 1983.
- Steffens DC, Otey E, Alexopoulos GS, Butters MA, Cuthbert B, Ganguli M, Geda YE, Hendrie HC, Krishnan RR, Kumar A, Lopez OL, Lyketsos CG, Mast BT, Morris JC, Norton MC, Peavy GM, Petersen RC, Reynolds CF, Salloway S, Welsh-Bohmer KA, Yesavage J: Perspectives on depression, mild cognitive impairment, and cognitive decline. Arch Gen Psychiatry 2006;63:130–138.
- Devanand DP, Sano M, Tang MX, Taylor S, Gurland BJ, Wilder D, Stern Y, Mayeux R: Depressed mood and the incidence of Alzheimer’s disease in the elderly living in the community. Arch Gen Psychiatry 1996;53:175–182.
- Rozzini L, Vicini Chilovi B, Trabucchi M, Padovani A: Depression is unrelated to conversion to dementia in patients with mild cognitive impairment. Arch Neurol 2005;62:505.
-
Rozzini L, Vicini Chilovi B, Trabucchi M, Padovani A: Loneliness but not depressive symptoms is independently related to conversion to dementia in MCI. Neurology, in press.
- Whiteside SP, Port JD, Deacon BJ, Abramowitz JS: A magnetic resonance spectroscopy investigation of obsessive-compulsive disorder and anxiety. Psychiatry Res 2006;146:137–147.
- Luis CA, Loewenstein DA, Acevedo A, Barker WW, Duara R: Mild cognitive impairment. Directions for future research. Neurology 2003;61:438–444.
- Tschanz JT, Welsh-Bohmer KA, Lyketsos CG, et al: Conversion to dementia from mild cognitive disorder: the Cache County Study. Neurology 2006;67:229–234.
- Galvin JE, Malcolm H, Johnson D, Morris JC: Personality traits distinguishing dementia with Lewy bodies from Alzheimer disease. Neurology 2007;68:1895–1901.
-
Rozzini L, Vicini Chilovi B, Bertoletti E, et al: Mild parkinsonian signs and psycho-behavioral symptoms in subjects with mild cognitive impairment. Int Psychogeriatr, in press.
- Rozzini L, Vicini Chilovi B, Bertoletti E, et al: Cognitive and psychopathologic response to rivastigmine in dementia with Lewy bodies compared to Alzheimer’s disease: a case control study. Am J Alzheimers Dis Other Demen 2007;22:42–47.
Article / Publication Details
Accepted: May 09, 2007
Published online: November 19, 2007
Issue release date: December 2007
Number of Print Pages: 5
Number of Figures: 0
Number of Tables: 2
ISSN: 1420-8008 (Print)
eISSN: 1421-9824 (Online)
For additional information: https://www.karger.com/DEM
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Get Permission